Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 10
Submit an article Journal homepage
444
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Late-onset neutropenia following primary treatment of diff use large B-cell lymphoma with rituximab-containing therapy

Samo RozmanInstitute of Oncology Ljubljana, Slovenia
,
Monika SoncInstitute of Oncology Ljubljana, Slovenia
&
Barbara Jezersek NovakovicInstitute of Oncology Ljubljana, SloveniaCorrespondence[email protected]
Pages 1945-1948 | Received 18 Jan 2012, Accepted 18 Mar 2012, Published online: 21 May 2012

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marta Pérez-De-Lis, Soledad Retamozo, Alejandra Flores-Chávez, Belchin Kostov, Roberto Perez-Alvarez, Pilar Brito-Zerón & Manuel Ramos-Casals. (2017) Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry). Expert Opinion on Drug Safety 16:11, pages 1255-1271.
Read now

Articles from other publishers (10)

Tejas S. Athni & Sara Barmettler. (2023) Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab. Annals of Allergy, Asthma & Immunology 130:6, pages 699-712.
Crossref
Ramon Diez-Feijóo, Juan Jose Rodríguez-Sevilla, Concepcion Fernández-Rodríguez, Solange Flores, Carmen Raya, Ana Ferrer, Luis Colomo & Antonio Salar. (2022) Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine. Frontiers in Immunology 12.
Crossref
Clara Grazia Chisari, Eleonora Sgarlata, Sebastiano Arena, Simona Toscano, Maria Luca & Francesco Patti. (2021) Rituximab for the treatment of multiple sclerosis: a review. Journal of Neurology 269:1, pages 159-183.
Crossref
B. Verriere, L. Gastaud, E. Chamorey, F. Peyrade, E. Deletie, K. Bouredji, D. Quinsat, R. Schiappa, A. Thyss & D. Re. (2018) Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab. Hematological Oncology 36:1, pages 144-149.
Crossref
David Aguiar-Bujanda, María Jesús Blanco-Sánchez, María Hernández-Sosa, Saray Galván-Ruíz, Samuel Hernández-Sarmiento, Salvador Saura-Grau & Uriel Bohn-Sarmiento. (2015) Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 15:12, pages 761-765.
Crossref
K. Kamei, M. Takahashi, M. Fuyama, K. Saida, H. Machida, M. Sato, M. Ogura & S. Ito. (2014) Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature. Nephrology Dialysis Transplantation 30:1, pages 91-96.
Crossref
Junshik Hong, Hyun Seon Woo, Hyunchul Kim, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Jeong Yeal Ahn, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2014) Anemia as a useful biomarker in patients with diffuse large B‐cell lymphoma treated with R‐ CHOP immunochemotherapy . Cancer Science 105:12, pages 1569-1575.
Crossref
Kazuya Kabei, Junji Uchida, Tomoaki Iwai, Takeshi Yamasaki, Nobuyuki Kuwabara, Toshihide Naganuma, Norihiko Kumada & Tatsuya Nakatani. (2014) Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil. Transplant Immunology 31:2, pages 92-97.
Crossref
Annika Plate, Joachim Havla & Tania Kümpfel. (2014) Late-onset neutropenia during long-term rituximab therapy in neuromyelitis optica. Multiple Sclerosis and Related Disorders 3:2, pages 269-272.
Crossref
Hideki Ishida, Masashi Inui, Miyuki Furusawa & Kazunari Tanabe. (2013) Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation — Single-center study. Transplant Immunology 28:2-3, pages 93-99.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.